Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0684
G

Failure to Administer Insulin and Monitor Blood Glucose Leads to Resident Harm

Thousand Oaks, California Survey Completed on 12-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A 65-year-old resident with multiple complex medical conditions, including diabetes mellitus, cerebral infarction, hypertension, hemiplegia, chronic myelogenous leukemia, anemia, drug-induced polyneuropathy, atrial fibrillation, dysphagia, and a gastrostomy tube, was admitted to the facility. The resident had a physician's order for Glargine (insulin) to be administered every 12 hours for diabetes management. However, Glargine was not administered for three consecutive days at several scheduled times. Documentation indicated that the medication was not given due to new admission and unavailability, but there was no evidence that the physician or pharmacist was notified about the missed doses. Additionally, the facility failed to use the emergency medication kit to obtain the insulin, and staff did not seek assistance when unsure how to proceed. The facility also failed to ensure proper medication administration practices. When the resident's prescribed Glargine was not available, a nurse administered insulin from another resident's supply, which was not properly labeled for the intended resident. This action was contrary to facility policy, which prohibits borrowing medications between residents. Furthermore, the order for finger stick blood sugar (FSBS) monitoring was not clarified with the physician, and the correct monitoring frequency was not established. As a result, no blood glucose monitoring was performed during the resident's stay, and the need for such monitoring was not recognized by the nursing staff. Due to these failures, the resident experienced a critically high blood glucose level (593 mg/dL), which was identified through abnormal lab results. The physician was notified only after this result, and the resident was subsequently transferred to an acute care hospital for evaluation and treatment of uncontrolled diabetes. The resident ultimately died following the transfer. The facility's policies and procedures for medication administration, medication procurement, and diabetes management were not followed, and staff interviews revealed a lack of knowledge and experience in handling new admissions, medication errors, and diabetes care.

An unhandled error has occurred. Reload 🗙